Expo West reflections: post-recession buy-outs and GMP compliance
![Expo West reflections: post-recession buy-outs and GMP compliance](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/7/7/1/6/266177-1-eng-GB/Expo-West-reflections-post-recession-buy-outs-and-GMP-compliance.jpg)
Shane Starling sat down with Frank Jaksch, the president and CEO of California-based third party testing company, Chromadex, to assess the ramifications of this kind of consolidation.
When Good Manufacturing Practices (GMP) – which smaller players are due to comply with this June – are thrown into the equation, Jaksch expects a more concentrated market with less products, and less complicated products.
Jaksch also offers tips to meet GMP demands and reduce compliance costs.